NZ215969A - Process for preparing and purifying recombinant interferon - Google Patents

Process for preparing and purifying recombinant interferon

Info

Publication number
NZ215969A
NZ215969A NZ215969A NZ21596986A NZ215969A NZ 215969 A NZ215969 A NZ 215969A NZ 215969 A NZ215969 A NZ 215969A NZ 21596986 A NZ21596986 A NZ 21596986A NZ 215969 A NZ215969 A NZ 215969A
Authority
NZ
New Zealand
Prior art keywords
preparing
recombinant interferon
purifying recombinant
interferon
purifying
Prior art date
Application number
NZ215969A
Inventor
Gerhard Bodo
Ingrid Maurer-Fogy
Edgar Falkner
Silvia Jutta Lindner
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NZ215969A publication Critical patent/NZ215969A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The process yields a highly pure, non-immunogenic, homogeneous alpha -interferon which has antiviral and immunoregulatory activity.
NZ215969A 1985-04-27 1986-04-28 Process for preparing and purifying recombinant interferon NZ215969A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3515336A DE3515336C2 (en) 1985-04-27 1985-04-27 Process for the preparation and purification of â-interferon

Publications (1)

Publication Number Publication Date
NZ215969A true NZ215969A (en) 1990-08-28

Family

ID=6269344

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ215969A NZ215969A (en) 1985-04-27 1986-04-28 Process for preparing and purifying recombinant interferon

Country Status (20)

Country Link
EP (1) EP0203382B1 (en)
JP (1) JP2566919B2 (en)
KR (1) KR940010024B1 (en)
AT (1) ATE94588T1 (en)
AU (1) AU598460B2 (en)
CA (1) CA1340281C (en)
DE (2) DE3515336C2 (en)
DK (1) DK186486A (en)
ES (1) ES8707554A1 (en)
FI (1) FI861748A (en)
GR (1) GR861093B (en)
HU (1) HU202883B (en)
IE (1) IE61444B1 (en)
IL (1) IL78604A (en)
NO (1) NO166727C (en)
NZ (1) NZ215969A (en)
PH (1) PH30912A (en)
PT (1) PT82452B (en)
SU (1) SU1591814A3 (en)
ZA (1) ZA863108B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
DE3813124A1 (en) * 1988-04-15 1989-10-26 Krieg Benno Distillable buffer solutions and their uses
EP1104809A1 (en) * 1994-04-09 2001-06-06 F. Hoffmann-La Roche Ag Process for producing alpha-interferon
KR100369582B1 (en) * 1995-09-04 2003-04-03 동아제약 주식회사 Purification method of recombinant alpha-interferon
TW577894B (en) * 1998-11-12 2004-03-01 Schering Corp Methods for conversion of protein isoforms and products thereof
ITBO20010426A1 (en) * 2001-07-06 2003-01-06 Alfa Wassermann Spa PHARMACOLOGICALLY ACTIVE PROTEIN PURIFICATION PROCESS BY CATIONIC EXCHANGE CHROMATOGRAPHY
ATE489400T1 (en) 2002-09-06 2010-12-15 Genentech Inc PROTEIN EXTRACTION METHOD
GB0818228D0 (en) * 2008-10-06 2008-11-12 Avecia Biolog Ltd Purification process
CN114814000B (en) * 2022-03-30 2024-07-23 深圳科兴药业有限公司 Method for detecting content of recombinant human interferon

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor
FI77877C (en) * 1979-04-20 1989-05-10 Technobiotic Ltd Process for the preparation and purification of human Le-shaped interferon protein.
ZA814375B (en) * 1980-07-01 1982-07-28 Hoffmann La Roche Interferons and process for their preparation
CH657141A5 (en) * 1980-07-01 1986-08-15 Hoffmann La Roche DNA SEQUENCES, RECOMBINANT EXPRESSION VECTORS FOR THE MICROBIAL PRODUCTION OF HUMAN LEUKOCYTE INTERFERON AND TRANSFORMED MICROORGANISMS.
US4364863A (en) * 1980-12-29 1982-12-21 Schering Corporation Extraction of interferon from bacteria
DE3220116A1 (en) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach MICROBIOLOGICALLY MANUFACTURED (ALPHA) AND SS INTERFERONES, DNA SEQUENCES CODING FOR THESE INTERFERONES, MICROORGANISMS CONTAINING THIS GENETIC INFORMATION, AND METHOD FOR THE PRODUCTION THEREOF
US4534906A (en) * 1982-11-01 1985-08-13 Genentech, Inc. Removal of impurities from human leukocyte interferon preparations
DE3382547D1 (en) * 1983-01-12 1992-05-27 Chiron Corp SECRETORIC EXPRESSION IN EUKARYOTS.
DE3306060A1 (en) * 1983-02-22 1984-08-23 Boehringer Ingelheim International GmbH, 6507 Ingelheim NEW IMMUNGLOBULIN-PRODUCING HYBRID CELL LINES, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
PT82452A (en) 1986-05-01
DE3515336A1 (en) 1987-01-22
NO861635L (en) 1986-10-28
PT82452B (en) 1988-11-30
ES8707554A1 (en) 1987-08-01
JPS61282098A (en) 1986-12-12
DE3689008D1 (en) 1993-10-21
DK186486A (en) 1986-10-28
PH30912A (en) 1997-12-23
JP2566919B2 (en) 1996-12-25
CA1340281C (en) 1998-12-22
KR940010024B1 (en) 1994-10-20
FI861748A (en) 1986-10-28
DE3515336C2 (en) 1994-01-20
NO166727B (en) 1991-05-21
IE61444B1 (en) 1994-11-02
SU1591814A3 (en) 1990-09-07
IL78604A (en) 1991-11-21
AU5677586A (en) 1986-10-30
KR860008270A (en) 1986-11-14
ES554372A0 (en) 1987-08-01
EP0203382A2 (en) 1986-12-03
ZA863108B (en) 1987-12-30
AU598460B2 (en) 1990-06-28
NO166727C (en) 1991-08-28
FI861748A0 (en) 1986-04-25
HU202883B (en) 1991-04-29
HUT41073A (en) 1987-03-30
EP0203382B1 (en) 1993-09-15
GR861093B (en) 1986-08-26
EP0203382A3 (en) 1988-04-27
IL78604A0 (en) 1986-08-31
IE861095L (en) 1986-10-27
ATE94588T1 (en) 1993-10-15
DK186486D0 (en) 1986-04-23

Similar Documents

Publication Publication Date Title
PT82736A (en) Process for preparing hybrid interferons
ZA868609B (en) Thienooxazinones,processes for their preparation,and their use as yield promoters
AU6384186A (en) Quadrulobe-type shaped catalytic extrudates
EP0602864A3 (en) Palladium containing metal oxide catalyst.
AU7937787A (en) Carriage type conveyor
NZ215969A (en) Process for preparing and purifying recombinant interferon
GB2186569B (en) Process for preparing 4, 4'-dihydroxydiphenyl sulfone having high purity
PT82802B (en) Process for preparing 1,8 bridged 4-quinolone-3-carboxylic acids useful as medicaments
CS580386A2 (en) Zpusob utesneni podlozi nebo materialu, jako napriklad malty, pojiva nebo betonu, pomoci injektaze
DE3660588D1 (en) Process for preparing alpha, omega-haloperfluoroalkanes
EP0264933A3 (en) Negative feedback system
EP0244427A4 (en) Recombinant virus.
DE3661820D1 (en) Process for preparing optionally-substituted 2-benzyl toluenes
ES2002161A6 (en) Process and intermediates for antiarrhytmic 1,3-diazabicyclo/4.4.0/dec-2-en-4-ones.
EP0288901A3 (en) Recombinant human glutathione peroxidase, process for preparing the same and dna coding the same
EP0258032A3 (en) Processes and intermediates for n-(s-3-alkylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine
GB8603797D0 (en) Recombinant catalysts
CS614986A1 (en) Zarizeni pro vstrikovani paliva, zemen pro motory s primym vstrikem paliva
SG134394G (en) Genetic sequences, type I interferon peptide coded by them, and these organisms producing the same
PL253377A1 (en) Process for preparing 1,2-bis/sylil/-ethenes
PL253378A1 (en) Process for preparing 1,2-bis/sylil/-ethenes
IE852439L (en) Medicaments with g.r.f. activity
GB8615578D0 (en) Group feedback system
ZA877711B (en) Shaping workpieces
YU93685A (en) One-group shunting stations